<?xml version="1.0"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.0//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/static/PubMed.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Shahroud University of Medical siences</PublisherName>
      <JournalTitle>Shahroud Journal of Medical Sciences</JournalTitle>
      <Issn>2423-6594</Issn>
      <Volume>12</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2026</Year>
        <Month>06</Month>
        <Day>03</Day>
      </PubDate>
    </Journal>
    <ArticleTitle>The Effect of Adjunctive Midazolam on Fentanyl Analgesia and Anxiolysis in Acute Limb Trauma: A Randomized Controlled Trial</ArticleTitle>
    <FirstPage>9</FirstPage>
    <LastPage>12</LastPage>
    <Language>eng</Language>
    <AuthorList>
      <Author>
        <FirstName>Mozhgan</FirstName>
        <LastName>Sabzevari</LastName>
        <Affiliation>Department of Emergency Medicine, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.. dr.sabzevari7@gmail.com</Affiliation>
      </Author>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Mahdavi</LastName>
        <Affiliation>Department of Epidemiology, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.. s.mahdavi88@gmail.com</Affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Farjamfar</LastName>
        <Affiliation>Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran.. m.farjamfar@yahoo.com</Affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Noyani</LastName>
        <Affiliation>Department of Emergency Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.. noyaniamir@gmail.com</Affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Khorsand</LastName>
        <Affiliation>Department of Emergency Medicine, Bahar Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.. dr_Khorsandmd@yahoo.com</Affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Enayatrad</LastName>
        <Affiliation>Clinical Research Development Unit, Bahar Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.. mostafaenayatrad@gmail.com</Affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Abbaszadeh</LastName>
        <Affiliation>Department of Emergency Medicine, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.. maryamabbaszadehmsp@gmail.com</Affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Meysam</FirstName>
        <LastName>Yekesadat</LastName>
        <Affiliation>Clinical Research Development Unit, Imam Hossein Hospital, Shahroud University of Medical Sciences, Shahroud, Iran.. dr.semeye@gmail.com</Affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Amiri Largani</LastName>
        <Affiliation>Department of Emergency Medicine, School of Medicine, Shahroud University of Medical Sciences, Shahroud, Iran.. amirilargani@gmail.com</Affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>01</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <Abstract>
Background: We compared combined midazolam&#x2013;fentanyl versus fentanyl alone for anxiety and pain relief in adult limb trauma patients.


Methods: In this double-blind randomized trial at Imam Hossein Hospital (Shahroud, Iran) during 2021, 78 adults (18&#x2013;80 years) with direct limb trauma (GCS=15, SBP&gt;90 mmHg) were randomly assigned to receive IV fentanyl (1 &#xB5;g/kg) plus either 1 mL saline or midazolam (1 mg if &lt;50 kg, 2 mg if 50&#x2013;75 kg, 3 mg if &gt;75 kg). Pain was assessed by Visual Analog Scale (VAS) at baseline, 30 min, and 60 min; anxiety by Depression Anxiety Stress Scales (DASS) before and 60 min post injection. Vital signs and adverse events were monitored; a rescue dose was given if VAS did not decrease by &#x2265;2 points at 30 min. Repeated measures ANOVA, paired and unpaired t-tests, and chi-square tests were applied with &#x3B1;=0.05.


Results: Both groups had significant reductions in pain over time (P-value=0.001) and anxiety (P-value=0.001). Between-group differences were nonsignificant for pain at 30 min (P-value=0.697) and 60 min (P-value=0.124) and for anxiety (P-value=0.802). No episodes of hypotension or respiratory depression occurred.


Conclusion: Co-administration of midazolam augments fentanyl&#x2019;s anxiolytic effect and provides equivalent analgesia without additional cardiorespiratory compromise.
</Abstract>
  </Article>
</ArticleSet>